Long-Term Assets: The sum of all assets classified as non-current.
Organogenesis (ORGO) had Long-Term Assets of $210.08M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$150.86M |
|
$14.53M |
|
$36.25M |
|
$114.61M |
|
$130.14M |
|
$20.73M |
|
$0.43M |
|
$21.16M |
|
$21.16M |
|
$21.57M |
|
$21.57M |
|
$21.57M |
|
$21.57M |
|
$20.73M |
|
$27.71M |
|
126.88M |
|
130.85M |
|
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$299.75M |
|
$78.06M |
|
|
Long-Term Assets |
$210.08M |
$509.83M |
|
$90.32M |
|
$2.09M |
|
$164.38M |
|
$254.70M |
|
$255.13M |
|
$216.41M |
|
$255.13M |
|
126.91M |
|
| Cash Flow Statement Financials | |
$-49.73M |
|
$-9.50M |
|
$-12.55M |
|
$136.15M |
|
$64.37M |
|
$-71.78M |
|
$8.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.32 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
75.97% |
|
13.74% |
|
13.74% |
|
-- |
|
14.03% |
|
9.63% |
|
$-59.23M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
0.92 |
|
0.89 |
|
100.69 |
|
8.45% |
|
9.97% |
|
4.23% |
|
8.38% |
|
$2.01 |
|
$-0.45 |
|
$-0.38 |
|